Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10211 |
| Vaccine Name | rDEN3delta30/31-7164 |
| Disease Name | Dengue fever |
| Disease Classification | Hemorrhagic |
| Virus Name | Dengue virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Live-attenuated |
| Vaccine Status | Phase 1 |
| Manufacturer | National Institute of Allergy and Infectious Diseases |
| Year of Manufacturing | 2013 |
| Manufacturing Country | USA |
| Age | 18 - 50 years |
| Dosage | NA |
| Administration Route | Subcutaneous |
| Adjuvant | NA |
| Target Strain | Dengue virus serotypes -3 |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | Johns Hopkins Bloomberg School of Public Health |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT00831012 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT00831012?recrs=abde&cond=dengue+fever&phase=0123&draw=2&rank=12 |
| Additional Links | NA |